Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,753Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M3,753EPS $0Operating Margin %-570.3F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0.4Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M15.8ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with IBB

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IBBJohn Griffin 2009-06-30 Sold Out -0.8%$63.11 - $72.98
($67.01)
$ 254.06279%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IBB is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


IBB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CONDON PHILIP GPortfolio Manager 2013-11-26Buy3,000$11.752062.21 view
GABELLI MARIO JControl Person of Adviser 2013-11-26Sell35,600$21.471083.33 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$15.761512.06 view
FRIEDRICH ROMAN IIITrustee 2013-11-25Buy100$21.481082.77 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$18.191296.7 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy135$17.81327.3 view
CONDON PHILIP GPortfolio Manager 2013-11-22Buy8,500$11.82053.05 view
Dammeyer Rodney FDirector 2013-11-22Buy31,940$6.164024.35 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy107$18.061306.76 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy113$18.091304.42 view

Press Releases about IBB :

    Quarterly/Annual Reports about IBB:

      News about IBB:

      Articles On GuruFocus.com

      More From Other Websites
      Shorts destroyed: The risks of betting on a bubble bursting Jul 25 2014
      The Fed Calls Out Biotech... Is It Time To Sell? Jul 24 2014
      [video] Pro confident market heads higher Jul 23 2014
      [video] What's coming in biotech? Jul 23 2014
      [video] Power Countdown: Biotech, social & Internet Jul 23 2014
      This Is The Problem With Listening To Janet Yellen About Biotech Stocks Jul 23 2014
      Biogen Idec: Biggest Beat in 10 Years, Largest Leap in Eight Months Jul 23 2014
      A Biotech Stock Is Up Nearly 300% After Announcing A Breast Cancer Drug Breakthrough Jul 23 2014
      Questions To Ask Before You Buy An ETF Jul 22 2014
      Big Week of Earnings for Big Biotech ETF Jul 21 2014
      [video] Pharma inversion deals Jul 18 2014
      [video] Analyst calls out Yellen's biotech comments Jul 18 2014
      ISI Biotech Analyst to Janet Yellen: What Bubble? Jul 18 2014
      An Open Letter To Janet Yellen: Is There A Biotech Bubble? Jul 18 2014
      Must-know: 2 stock market segments offering good value Jul 17 2014
      [video] Closing Bell Exchange: Who supports the stock market? Jul 16 2014
      Sector Spotlight: iShares Nasdaq Biotech $IBB-Preliminary Support @ 244-245 Jul 16 2014
      [video] Cramer's Stop Trading: Yellen effect Jul 16 2014
      The Zacks Analyst Blog Highlights: Intel, Yahoo, CSX, Global X Social Media Index ETF and iShares... Jul 16 2014
      [video] Yellen warns on social media, biotech valuations Jul 15 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide